{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:Gamma_secretase",
      "entity_text" : "gamma-secretase",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Previously, we have demonstrated that inhibitors of gamma-secretase, an enzyme required for Notch1 activation, can attenuate the severity of RA indices and suppress proinflammatory cytokines (TNF-alpha, IFN-gamma, IL-6, IL-12, IL-17 and MCP-1), NF-kappaB, and MMP-3 in RA synoviocytes and in collagen induced arthritis (CIA) mice XREF_BIBR, XREF_BIBR.",
  "reading_complete" : "2020-08-03T10:26:14Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:25:17Z",
  "trigger" : "suppress",
  "evidence" : [ "gamma-secretase, an enzyme required for Notch1 activation, can attenuate the severity of RA indices and suppress proinflammatory cytokines (TNF-alpha, IFN-gamma, IL-6, IL-12, IL-17 and MCP-1), NF-kappaB" ],
  "pmc_id" : "6160763",
  "score" : 0
}